$RMD
RESMED INC Stock $rmd

$rmd Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000094381924000027 Filed on October 25, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$1.225B	$1.102B
YoY Change		11.08%	16.0%
Cost Of Revenue		$507.3M	$502.3M
YoY Change		1.0%	22.66%
Gross Profit		$717.2M	$600.1M
YoY Change		19.52%	10.96%
Gross Profit Margin		58.57%	54.44%
Selling, General & Admin		$239.0M	$222.9M
YoY Change		7.23%	14.92%
% of Gross Profit		33.32%	37.14%
Research & Development		$79.52M	$75.71M
YoY Change		5.04%	19.82%
% of Gross Profit		11.09%	12.62%
Depreciation & Amortization		$44.73M	$44.93M
YoY Change		-0.45%	23.88%
% of Gross Profit		6.24%	7.49%
Operating Expenses		$329.9M	$311.1M
YoY Change		6.06%	17.35%
Operating Profit		$387.3M	$289.0M
YoY Change		34.02%	4.81%
Interest Expense		-$1.661M	-$19.45M
YoY Change		-91.46%	56.36%
% of Operating Profit		-0.43%	-6.73%
Other Income/Expense, Net		-$3.815M	-$16.81M
YoY Change		-77.3%	20.51%
Pretax Income		$383.5M	$272.2M
YoY Change		40.89%	3.97%
Income Tax		$72.14M	$52.77M
% Of Pretax Income		18.81%	19.39%
Net Earnings		$311.4M	$219.4M
YoY Change		41.9%	4.25%
Net Earnings / Revenue		25.43%	19.91%
Basic Earnings Per Share		$2.12	$1.49
Diluted Earnings Per Share		$2.11	$1.49
COMMON SHARES
Basic Shares Outstanding	146.8M shares	146.9M shares	147.1M shares
Diluted Shares Outstanding		147.6M shares	147.5M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$426.4M	$209.1M
YoY Change	103.9%	0.94%
Cash & Equivalents	$426.4M	$209.1M
Short-Term Investments
Other Short-Term Assets	$213.0M	$161.7M
YoY Change	31.75%	28.17%
Inventory	$918.0M	$958.2M
Prepaid Expenses
Receivables	$811.2M	$692.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.641B	$2.305B
YoY Change	14.6%	13.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$560.2M	$534.0M
YoY Change	4.91%	9.56%
Goodwill	$2.886B	$2.812B
YoY Change	2.63%	45.04%
Intangibles
YoY Change
Long-Term Investments	$69.29M	$62.16M
YoY Change	11.46%	687.85%
Other Assets	$278.9M	$265.1M
YoY Change	5.18%	52.86%
Total Long-Term Assets	$4.581B	$4.436B
YoY Change	3.27%	41.11%
TOTAL ASSETS
Total Short-Term Assets	$2.641B	$2.305B
Total Long-Term Assets	$4.581B	$4.436B
Total Assets	$7.222B	$6.741B
YoY Change	7.15%	30.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$249.3M	$177.0M
YoY Change	40.8%	-2.44%
Accrued Expenses	$365.7M	$348.3M
YoY Change	5.02%	7.47%
Deferred Revenue	$157.2M	$146.7M
YoY Change	7.14%	35.61%
Short-Term Debt	$9.896M	$9.905M
YoY Change	-0.09%	-0.01%
Long-Term Debt Due	$9.896M	$9.905M
YoY Change	-0.09%	-0.01%
Total Short-Term Liabilities	$904.1M	$770.8M
YoY Change	17.29%	11.28%
LONG-TERM LIABILITIES
Long-Term Debt	$667.6M	$1.352B
YoY Change	-50.61%	72.07%
Other Long-Term Liabilities	$83.27M	$34.33M
YoY Change	142.57%	488.01%
Total Long-Term Liabilities	$1.123B	$1.720B
YoY Change	-34.68%	63.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$904.1M	$770.8M
Total Long-Term Liabilities	$1.123B	$1.720B
Total Liabilities	$2.027B	$2.490B
YoY Change	-18.59%	42.74%
SHAREHOLDERS EQUITY
Retained Earnings	$5.225B	$4.402B
YoY Change	18.7%	17.08%
Common Stock	$1.925B	$1.791B
YoY Change	7.44%	5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.195B	$4.250B
YoY Change
Total Liabilities & Shareholders Equity	$7.222B	$6.741B
YoY Change	7.15%	30.19%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$311.4M	$219.4M
YoY Change	41.9%	4.25%
Depreciation, Depletion And Amortization	$44.73M	$44.93M
YoY Change	-0.45%	23.88%
Cash From Operating Activities	$325.5M	$286.3M
YoY Change	13.71%	541.0%
INVESTING ACTIVITIES
Capital Expenditures	$17.84M	$30.04M
YoY Change	-40.6%	3.37%
Acquisitions	$0.00	$103.2M
YoY Change	-100.0%	440.23%
Other Investing Activities	$21.75M	-$108.1M
YoY Change	-120.12%	309.01%
Cash From Investing Activities	$2.146M	-$149.0M
YoY Change	-101.44%	153.34%
FINANCING ACTIVITIES
Cash Dividend Paid	$77.89M	$70.60M
YoY Change	10.33%	9.57%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$30.00M	$185.0M
YoY Change	-83.78%	516.67%
Cash From Financing Activities	-$150.8M	-$151.1M
YoY Change	-0.25%	260.87%
NET CHANGE
Cash From Operating Activities	$325.5M	$286.3M
Cash From Investing Activities	$2.146M	-$149.0M
Cash From Financing Activities	-$150.8M	-$151.1M
Net Change In Cash	$188.0M	-$18.79M
YoY Change	-1100.48%	-71.76%
FREE CASH FLOW
Cash From Operating Activities	$325.5M	$286.3M
Capital Expenditures	$17.84M	$30.04M
Free Cash Flow	$307.7M	$256.2M
YoY Change	20.08%	1541.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Entity File Number EntityFileNumber	001-15317
CY2024Q3	dei	Entity Address Country EntityAddressCountry	US
CY2024Q3	dei	City Area Code CityAreaCode	858
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	836-5000
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.004 per share
CY2024Q3	dei	Trading Symbol TradingSymbol	RMD
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	311355000	usd
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	137343000	usd
CY2024Q3	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	83521000	usd
CY2024Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	79339000	usd
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000943819
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	ResMed Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	9001 Spectrum Center Blvd.
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	146795746	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426361000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238361000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23600000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	21132000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	811198000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	837275000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	917982000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	822250000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	459833000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	2641125000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	2357719000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	560211000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	548025000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	157068000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	151121000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2886017000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2842055000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	478613000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	485904000	usd
CY2024Q3	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	220530000	usd
CY2024Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	203569000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	278853000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	284001000	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	4581292000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	4514675000	usd
CY2024Q3	us-gaap	Assets Assets	7222417000	usd
CY2024Q2	us-gaap	Assets Assets	6872394000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	249278000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	237728000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	365749000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28278000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25278000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	157188000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	152554000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	93690000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	107517000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	9896000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9900000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	904079000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	910655000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	144453000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	141444000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	83270000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42257000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	667578000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	697313000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189565112	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146901045	shares
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44730000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44934000	usd
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	485584000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	144490000	usd
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92123
CY2024Q3	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q2	us-gaap	Derivative Asset Current Statement Of Financial Position Extensible Enumeration DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q2	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3	us-gaap	Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2	us-gaap	Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2	us-gaap	Derivative Liability Current Statement Of Financial Position Extensible Enumeration DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0152841
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	377678000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1123312000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1097696000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	2027391000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	2008351000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189662212	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146776149	shares
CY2024Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	758000	usd
CY2024Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	588000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1924584000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1896604000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5225111000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4991647000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	42886063	shares
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	42664067	shares
CY2024Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1823272000	usd
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1773267000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132155000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-251529000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5195026000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4864043000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7222417000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6872394000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1224509000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1102321000	usd
CY2024Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	499620000	usd
CY2023Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	493353000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7670000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8908000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	507290000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	502261000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	717219000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	600060000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	238979000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	222874000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79524000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75710000	usd
CY2024Q3	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	11404000	usd
CY2023Q3	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	12479000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	329907000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	311063000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	387312000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	288997000	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1661000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-14957000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	963000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3895000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-680000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-602000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2437000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2648000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3815000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16806000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	383497000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	272191000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72142000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52769000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	311355000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	219422000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.53
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146861000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147075000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147599000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147486000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	311355000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	219422000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-21802000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-17093000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	141176000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30527000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	430729000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	171802000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4864043000	usd
CY2024Q3	rmd	Adjustments To Additional Paid In Capital Common Stock Adjustment AdjustmentsToAdditionalPaidInCapitalCommonStockAdjustment	0	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8383000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-389000	usd
CY2024Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	50005000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20156000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	119374000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.53
CY2024Q3	us-gaap	Dividends Dividends	77891000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	5195026000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4129903000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	983000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-225000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18510000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-47620000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	219422000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
CY2023Q3	us-gaap	Dividends Dividends	70597000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4250376000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	311355000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	219422000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44730000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44934000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8980000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8508000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	20156000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	18510000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	963000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3895000	usd
CY2024Q3	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-680000	usd
CY2023Q3	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-602000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-36417000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6534000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	70254000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-26911000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	123000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	42015000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-25440000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1018000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	325538000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	286283000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17840000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30035000	usd
CY2024Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1767000	usd
CY2023Q3	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10831000	usd
CY2024Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	103183000	usd
CY2024Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1350000	usd
CY2023Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3680000	usd
CY2024Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4128000	usd
CY2023Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	250000	usd
CY2024Q3	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-18975000	usd
CY2023Q3	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	1501000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2146000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-148980000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8383000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	983000	usd
CY2024Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	389000	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	225000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50005000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2024Q3	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	855000	usd
CY2023Q3	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	1293000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	105000000	usd
CY2024Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	30000000	usd
CY2023Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	185000000	usd
CY2024Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	77891000	usd
CY2023Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	70597000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-150757000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-151132000	usd
CY2024Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11073000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4962000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	188000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18791000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238361000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227891000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	426361000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209100000	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	105704000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	76749000	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	7351000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	14957000	usd
CY2024Q3	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	0	usd
CY2023Q3	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	34092000	usd
CY2024Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2023Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	5325000	usd
CY2024Q3	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	0	usd
CY2023Q3	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	74416000	usd
CY2024Q3	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	-855000	usd
CY2023Q3	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	-1293000	usd
CY2024Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	855000	usd
CY2023Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	104476000	usd
CY2024Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	24500000	usd
CY2023Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	22700000	usd
CY2024Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1224509000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1102321000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	373294000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	355570000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2465000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2713000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	542223000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	463967000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	917982000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	822250000	usd
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	126274000	usd
CY2024Q2	us-gaap	Prepaid Taxes PrepaidTaxes	107623000	usd
CY2024Q3	rmd	Prepaid Inventory PrepaidInventory	146324000	usd
CY2024Q2	rmd	Prepaid Inventory PrepaidInventory	172198000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	212986000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	180012000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	485584000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	459833000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1324965000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1274992000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	764754000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	726967000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	560211000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	548025000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	478613000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	485904000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2842055000	usd
CY2024Q3	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-279000	usd
CY2024Q3	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	44241000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2886017000	usd
CY2024Q3	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	16216000	usd
CY2024Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	12026000	usd
CY2024Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	65784000	usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	73739000	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	69287000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	65462000	usd
CY2024Q3	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	151287000	usd
CY2024Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	151227000	usd
CY2024Q2	rmd	Equity Investments EquityInvestments	151227000	usd
CY2024Q3	rmd	Additional Equity Investments AdditionalEquityInvestments	1350000	usd
CY2024Q3	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-4128000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	389000	usd
CY2024Q3	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	5259000	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	4190000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	963000	usd
CY2024Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	2555000	usd
CY2024Q3	rmd	Equity Investments EquityInvestments	151287000	usd
CY2023Q2	rmd	Equity Investments EquityInvestments	146537000	usd
CY2023Q3	rmd	Additional Equity Investments AdditionalEquityInvestments	3680000	usd
CY2023Q3	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-250000	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-602000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3895000	usd
CY2023Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-1810000	usd
CY2023Q3	rmd	Equity Investments EquityInvestments	143660000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-1100000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-600000	usd
CY2024Q3	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2024Q2	rmd	Short Term Debt Gross ShortTermDebtGross	10000000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	104000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	100000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	9896000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	9900000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	670000000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	700000000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2422000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2687000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	667578000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	697313000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	677474000	usd
CY2024Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	707213000	usd
CY2024Q3	rmd	Debt To Consolidated Ebitda Ratio DebtToConsolidatedEbitdaRatio	3.50
CY2024Q3	rmd	Line Of Credit Facility Collateral Percentage Of Company LineOfCreditFacilityCollateralPercentageOfCompany	0.10
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	159055000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	417364000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	311355000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	219422000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	146861000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147075000	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	738000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	411000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147599000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147486000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.49
CY2022Q2	rmd	Number Of Patents NumberOfPatents	7	patent
CY2023Q1	rmd	Number Of Patents NumberOfPatents	3	patent
CY2024Q3	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	51500000	usd
CY2023Q3	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	47700000	usd
CY2024Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	26400000	usd
CY2024Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	800000	usd
CY2024Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	35800000	usd
CY2024Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	800000	usd
CY2024Q3	us-gaap	Derivative Assets DerivativeAssets	24664000	usd
CY2024Q2	us-gaap	Derivative Assets DerivativeAssets	2432000	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	74733000	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	36538000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000943819-24-000027-index-headers.html	Edgar Link	pending
0000943819-24-000027-index.html	Edgar Link	pending
0000943819-24-000027.txt	Edgar Link	pending
0000943819-24-000027-xbrl.zip	Edgar Link	pending
exhibit101-resmedincnonxem.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmd-20240930.htm	Edgar Link	pending
rmd-20240930.xsd	Edgar Link	pending
rmd-20240930xex311.htm	Edgar Link	pending
rmd-20240930xex312.htm	Edgar Link	pending
rmd-20240930xex32.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rmd-20240930_cal.xml	Edgar Link	unprocessable
rmd-20240930_def.xml	Edgar Link	unprocessable
rmd-20240930_lab.xml	Edgar Link	unprocessable
rmd-20240930_pre.xml	Edgar Link	unprocessable
rmd-20240930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMD
RESMED INC Stock $rmd

2024 Q4 Form 10-Q Financial Statement

#000094381924000027 Filed on October 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD RESMED INC Stock $rmd

2024 Q4 Form 10-Q Financial Statement

#000094381924000027 Filed on October 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD
RESMED INC Stock $rmd